These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30887865)

  • 1. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study.
    Schrantee A; Solleveld MM; Schwantje H; Bruin WB; Mutsaerts HM; Adriaanse SM; Lucassen P; Booij J; Reneman L
    J Psychopharmacol; 2019 Jun; 33(6):660-669. PubMed ID: 30887865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.
    Schouw ML; Gevers S; Caan MW; Majoie CB; Booij J; Nederveen AJ; Reneman L
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):537-45. PubMed ID: 22209360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
    Schrantee A; Lucassen PJ; Booij J; Reneman L
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
    Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S
    Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function.
    Klomp A; Caan MW; Denys D; Nederveen AJ; Reneman L
    Neuroimage; 2012 Nov; 63(3):1695-700. PubMed ID: 22842212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
    Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.
    Hinz R; Selvaraj S; Murthy NV; Bhagwagar Z; Taylor M; Cowen PJ; Grasby PM
    J Cereb Blood Flow Metab; 2008 Aug; 28(8):1478-90. PubMed ID: 18478022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study.
    Solleveld MM; Schrantee A; Homberg JR; Lucassen PJ; Reneman L
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111126. PubMed ID: 32592855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans.
    Geday J; Hermansen F; Rosenberg R; Smith DF
    Synapse; 2005 Mar; 55(4):224-9. PubMed ID: 15668991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
    Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
    Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram.
    Chen Y; Wan HI; O'Reardon JP; Wang DJ; Wang Z; Korczykowski M; Detre JA
    Clin Pharmacol Ther; 2011 Feb; 89(2):251-8. PubMed ID: 21191380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study.
    Edes AE; McKie S; Szabo E; Kokonyei G; Pap D; Zsombok T; Hullam G; Gonda X; Kozak LR; McFarquhar M; Anderson IM; Deakin JFW; Bagdy G; Juhasz G
    Neuropharmacology; 2020 Jun; 170():107807. PubMed ID: 31593709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study.
    Boucherie DE; Reneman L; Booij J; Martins D; Dipasquale O; Schrantee A
    J Psychopharmacol; 2023 Dec; 37(12):1209-1217. PubMed ID: 37947344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
    Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.
    Sekar S; Verhoye M; Van Audekerke J; Vanhoutte G; Lowe AS; Blamire AM; Steckler T; Van der Linden A; Shoaib M
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):521-31. PubMed ID: 21103865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.